Showing results (21-30 of 2,905) with videos related to

Sort By:
Pageof 291
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosusAndrew A Welcher, Michael Boedigheimer, Alan J Kivitz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblastsBorbala Aradi, Masaru Kato, Maria Filkova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2015
Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkersMukundan Attur, Svetlana Krasnokutsky, Alexander Statnikov, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2019
Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty IndexAlexandra Legge, Susan Kirkland, Kenneth Rockwood, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 7, 2018
Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United StatesRichard A Furie, Daniel J Wallace, Cynthia Aranow, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental ArthritisRoman Fischer, Marcel Proske, Maëlle Duffey, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative RegulatorsMelissa J Mulla, Ingrid C Weel, Julie A Potter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic SclerosisAthina Dritsoula, Ioannis Papaioannou, Sandra G Guerra, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus ErythematosusR Ezequiel Borgia, Maya Gerstein, Deborah M Levy, et al.
Pageof 291